IDXX vs MDGL · P/E 40, rev $2.36B vs rev $675.6M
IDEXX Laboratories Inc (IDXX) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the IDXX and MDGL stock pages for the full models.
Not investment advice.